|
rs17632542
|
|
T |
0.750 |
GeneticVariation |
GWASDB |
When comparing prostate cancer cases with low PSA controls, alleles at genetic markers rs1512268, rs445114, rs10788160, rs11199874, rs17632542, rs266849, and rs2735839 were associated with an increased risk of prostate cancer, but the effect-estimates were attenuated to the null when using high PSA controls (Pheterogeneity in effect-estimates < 0.04).
|
24753544 |
2014 |
|
rs4775302
|
|
|
0.710 |
GeneticVariation |
GWASDB |
We found significant associations between aggressive prostate cancer and five single nucleotide polymorphisms (SNPs) in the 10q26 (rs10788165, rs10749408, and rs10788165, p value for association 1.3 × 10(-10 ) to 3.2 × 10(-11) ) and 15q21 (rs4775302 and rs1994198, p values for association 3.1 × 10(-8 ) to 8.2 × 10(-9)) regions.
|
22130093 |
2011 |
|
rs11672691
|
|
G |
0.720 |
GeneticVariation |
GWASDB |
We not only confirmed the association of a PrCa susceptibility locus, rs11672691 on chromosome 19, but also showed an association with aggressive PrCa [odds ratio = 1.12 (95% confidence interval 1.03-1.21), P = 1.4 × 10(-8)].
|
23065704 |
2013 |
|
rs721048
|
|
A |
0.710 |
GeneticVariation |
GWASDB |
Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively).
|
18264098 |
2008 |
|
rs5945572
|
|
A |
0.730 |
GeneticVariation |
GWASDB |
Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively).
|
18264098 |
2008 |
|
rs629242
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
|
18073375 |
2007 |
|
rs351855
|
|
|
0.780 |
GeneticVariation |
UNIPROT |
This meta-analysis showed the evidence that FGFR4 Gly388Arg polymorphism was associated with an increased risk of prostate cancer development and progression, suggesting that FGFR4 Gly388Arg polymorphism could be a marker for prostate cancer development and progression.
|
21349172 |
2011 |
|
rs902774
|
|
A |
0.710 |
GeneticVariation |
GWASDB |
The estimated per-allele odds ratios for these loci (1.14 for rs2292884 and 1.17 for rs902774) did not differ between advanced and non-advanced PrCa (case-only test for heterogeneity P= 0.72 and P= 0.61, respectively).
|
21743057 |
2011 |
|
rs2292884
|
|
G |
0.710 |
GeneticVariation |
GWASDB |
The estimated per-allele odds ratios for these loci (1.14 for rs2292884 and 1.17 for rs902774) did not differ between advanced and non-advanced PrCa (case-only test for heterogeneity P= 0.72 and P= 0.61, respectively).
|
21743057 |
2011 |
|
rs2242652
|
|
G |
0.710 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs10187424
|
|
A |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs10875943
|
|
C |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs10936632
|
|
A |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs130067
|
|
G |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs2121875
|
|
G |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs5919432
|
|
A |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs6763931
|
|
T |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs7584330
|
|
C |
0.700 |
GeneticVariation |
GWASDB |
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
21743467 |
2011 |
|
rs9623117
|
|
C |
0.700 |
GeneticVariation |
GWASDB |
Sequence variants at 22q13 are associated with prostate cancer risk.
|
19117981 |
2009 |
|
rs137852603
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
|
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
|
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
|
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
|
rs351855
|
|
|
0.780 |
GeneticVariation |
UNIPROT |
Our results indicate that the FGFR4 Arg allele of the Gly388Arg polymorphism and the G allele of the rs2011077 polymorphism have a significant impact on the development of prostate cancer and BPH, and the progression of prostate cancer in a Japanese population.
|
18756523 |
2008 |
|
rs11199874
|
|
|
0.700 |
GeneticVariation |
GWASDB |
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
|
22130093 |
2011 |